AFT Pharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Hartley Atkinson
最高経営責任者
NZ$974.8k
報酬総額
CEO給与比率 | 68.7% |
CEO在任期間 | 27.2yrs |
CEOの所有権 | 68.7% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 6.7yrs |
経営陣の近況
Recent updates
AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 17It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year
Jul 26AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
May 25Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?
May 22Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?
Oct 17Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?
May 23Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?
Dec 01We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise
Jul 30With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For
Jun 02Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?
Mar 20A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation
Feb 13Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 23Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?
Jan 02Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?
Dec 12AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 21CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | NZ$12m |
Jun 30 2024 | n/a | n/a | NZ$14m |
Mar 31 2024 | NZ$975k | NZ$670k | NZ$16m |
Dec 31 2023 | n/a | n/a | NZ$13m |
Sep 30 2023 | n/a | n/a | NZ$11m |
Jun 30 2023 | n/a | n/a | NZ$11m |
Mar 31 2023 | NZ$931k | NZ$606k | NZ$11m |
Dec 31 2022 | n/a | n/a | NZ$14m |
Sep 30 2022 | n/a | n/a | NZ$17m |
Jun 30 2022 | n/a | n/a | NZ$18m |
Mar 31 2022 | NZ$840k | NZ$578k | NZ$20m |
Dec 31 2021 | n/a | n/a | NZ$15m |
Sep 30 2021 | n/a | n/a | NZ$11m |
Jun 30 2021 | n/a | n/a | NZ$9m |
Mar 31 2021 | NZ$701k | NZ$506k | NZ$8m |
Dec 31 2020 | n/a | n/a | NZ$5m |
Sep 30 2020 | n/a | n/a | NZ$3m |
Jun 30 2020 | n/a | n/a | NZ$7m |
Mar 31 2020 | NZ$592k | NZ$443k | NZ$12m |
Dec 31 2019 | n/a | n/a | NZ$11m |
Sep 30 2019 | n/a | n/a | NZ$11m |
Jun 30 2019 | n/a | n/a | NZ$4m |
Mar 31 2019 | NZ$556k | NZ$431k | -NZ$3m |
Dec 31 2018 | n/a | n/a | -NZ$7m |
Sep 30 2018 | n/a | n/a | -NZ$11m |
Jun 30 2018 | n/a | n/a | -NZ$12m |
Mar 31 2018 | NZ$514k | NZ$429k | -NZ$14m |
報酬と市場: Hartleyの 総報酬 ($USD 568.29K ) は、 NZ市場 ($USD 589.98K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Hartleyの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Hartley Atkinson
27.2yrs
在職期間
NZ$974,785
報酬
Dr. Hartley Atkinson, M.Pharm (Dist), PhD, is Co-Founder of AFT Pharmaceuticals Limited in 1997. Dr. Atkinson is Chief Executive Officer of AFT Pharmaceuticals Limited since September 04, 1997 and also ser...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Founder | 27.2yrs | NZ$974.79k | 68.69% NZ$ 195.2m | |
Co-Founder | 12.2yrs | NZ$175.44k | データなし | |
Independent Non-Executive Director | 3.9yrs | NZ$161.04k | データなし | |
Independent Chairman | 9.4yrs | NZ$154.00k | 0.17% NZ$ 484.5k | |
Independent Non-Executive Director | 1.2yrs | NZ$50.38k | データなし | |
Independent Non-Executive Director | no data | データなし | データなし |
6.7yrs
平均在職期間
経験豊富なボード: AFTの 取締役会 は 経験豊富 であると考えられます ( 6.7年の平均在任期間)。